Literature DB >> 3293458

Immunohistochemical evidence of heterogeneity in macular corneal dystrophy.

C J Yang1, N SundarRaj, E J Thonar, G K Klintworth.   

Abstract

We used the avidin-biotin complex immunoperoxidase technique to test the reactivity of the abnormal corneal accumulations with five different monoclonal antibodies that recognize specific determinants on keratan sulfate. Eighty-eight corneas from 67 patients with macular corneal dystrophy were immunolabeled with the antibodies. In 31 corneas the abnormal accumulations did not react with any of the antikeratan sulfate antibodies, but 18 corneas reacted with all of the antibodies. The remaining corneas reacted with various combinations of the antibodies. The data suggest that the accumulations in macular corneal dystrophy are not always identical and that keratan sulfate is present in some cases but not in others. Thus, based on differences in the storage material, macular corneal dystrophy appears to manifest heterogeneity with at least two distinct varieties: keratan sulfate negative (type 1) and keratan sulfate positive (type 2).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293458     DOI: 10.1016/s0002-9394(14)76390-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Coexistence of macular corneal dystrophy types I and II in a single sibship.

Authors:  N P Liu; J Baldwin; F Lennon; J M Stajich; E J Thonar; M A Pericak-Vance; G K Klintworth; J M Vance
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

2.  Proteoglycans contain a 4.6 A repeat in muscular dystrophy corneas: x-ray diffraction evidence.

Authors:  A J Quantock; G K Klintworth; D J Schanzlin; M S Capel; M E Lenz; E J Thonar
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

3.  Impairment of the autophagy-lysosomal pathway and activation of pyroptosis in macular corneal dystrophy.

Authors:  Tao Zheng; Chuchu Zhao; Baowen Zhao; Hanruo Liu; Shijian Wang; Liyuan Wang; Ping Liu
Journal:  Cell Death Discov       Date:  2020-09-12

4.  Linkage of a gene for macular corneal dystrophy to chromosome 16.

Authors:  J M Vance; F Jonasson; F Lennon; J Sarrica; K F Damji; J Stauffer; M A Pericak-Vance; G K Klintworth
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

Review 5.  Structural and biochemical aspects of keratan sulphate in the cornea.

Authors:  Andrew J Quantock; Robert D Young; Tomoya O Akama
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

6.  Differential immunogold localisation of sulphated and unsulphated keratan sulphate proteoglycans in normal and macular dystrophy cornea using sulphation motif-specific antibodies.

Authors:  Robert D Young; Tomoya O Akama; Petra Liskova; Neil D Ebenezer; Bruce Allan; Briedgeen Kerr; Bruce Caterson; Michiko N Fukuda; Andrew J Quantock
Journal:  Histochem Cell Biol       Date:  2006-08-30       Impact factor: 4.304

7.  A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy.

Authors:  Jing Zhang; Dan Wu; Yue Li; Yidan Fan; Yiqin Dai; Jianjiang Xu
Journal:  Aging (Albany NY)       Date:  2019-02-04       Impact factor: 5.682

8.  Novel mutations of CHST6 in Iranian patients with macular corneal dystrophy.

Authors:  Shiva Akbari Birgani; Zivar Salehi; Masoud Houshmand; Mohamad Javad Mohamadi; Leila Azizade Promehr; Zahra Mozafarzadeh
Journal:  Mol Vis       Date:  2009-02-18       Impact factor: 2.367

9.  Immunophenotypes of macular corneal dystrophy in India and correlation with mutations in CHST6.

Authors:  Afia Sultana; Gordon K Klintworth; Eugene J-M A Thonar; Geeta K Vemuganti; Chitra Kannabiran
Journal:  Mol Vis       Date:  2009-02-09       Impact factor: 2.367

10.  Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6.

Authors:  Xiuhong Dang; Qingguo Zhu; Li Wang; Hong Su; Hui Lin; Nan Zhou; Ting Liang; Zheng Wang; Shangzhi Huang; Qiushi Ren; Yanhua Qi
Journal:  Mol Vis       Date:  2009-04-06       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.